Home › Research › Health systems and care delivery
Epidemiology of Homebound Population Among Beneficiaries of a Large National Medicare Advantage Plan
Bruce A. Leff, Christine Seel Ritchie, Sarah L. Szanton, Oren Shapira, Amanda J. Sutherland, Andy G. Lynch, Brian W. Powers, Mona Siddiqui et al.. Annals of Internal Medicine, 2024-08-12
Topic: Risk, prevention and care in population studies
Plain-language summary
In 2022, the overall prevalence of homebound beneficiaries was 22.0% (8.4% of beneficiaries were homebound, and 13.6% were semihomebound). In adjusted models, female sex (odds ratio [OR], 1.36 [95% CI, 1.35 to 1.37), low-income status or dual eligibility for Medicare and Medicaid (OR, 1.56 [CI, 1.55 to 1.57]), dementia (OR, 2.36 [CI, 2.33 to 2.39]), and moderate to severe frailty (OR, 4.32 [CI, 4.19 to 4.45]) were predictive of homebound status. In multivariable logistic regression, homebound status was associated with increased odds of any emergency department visit (OR, 1.14 [ CI, 1.14 to 1.15]), any inpatient hospital admission (OR, 1.44 [CI, 1.42 to 1.46]), any skilled-nursing facility admission (OR, 2.18 [CI, 2.13 to 2.23]), and death (OR, 2.55 [CI, 2.52 to 2.58]). LIMITATION: The study period overlapped the tail end of the COVID-19 pandemic, and data were derived from a single national MA plan, which limits generalizability. Overall homebound prevalence in a national MA plan was 22.0% and was independently associated with increased health service use and mortality. Study findings can inform strategic initiatives to identify and manage care for homebound beneficiaries. PRIMARY FUNDING SOURCE: Humana, under a collaborative research agreement with Johns Hopkins University.
What this study adds
Evidence grade: Low
This is a cross-sectional study. This study found that 22 percent of Medicare Advantage beneficiaries were homebound or semihomebound, and dementia was predictive of homebound status. Reported effect size: 22.0%; 8.4%; 13.6%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Leff, B. A., Ritchie, C. S., Szanton, S. L., Shapira, O., Sutherland, A. J., Lynch, A. G., et al. (2024). Epidemiology of Homebound Population Among Beneficiaries of a Large National Medicare Advantage Plan. Annals of Internal Medicine. https://doi.org/10.7326/m24-0011
Vancouver
Leff BA, Ritchie CS, Szanton SL, Shapira O, Sutherland AJ, Lynch AG, et al. Epidemiology of Homebound Population Among Beneficiaries of a Large National Medicare Advantage Plan. Annals of Internal Medicine. 2024. doi:10.7326/m24-0011. PMID: 39133927.
BibTeX
@article{leff2024-39133927,
author = {Leff, Bruce A. and Ritchie, Christine Seel and Szanton, Sarah L. and Shapira, Oren and Sutherland, Amanda J. and Lynch, Andy G. and Powers, Brian W. and Siddiqui, Mona and others},
title = {{Epidemiology of Homebound Population Among Beneficiaries of a Large National Medicare Advantage Plan}},
journal = {Annals of Internal Medicine},
year = {2024},
doi = {10.7326/m24-0011},
pmid = {39133927},
url = {https://doi.org/10.7326/m24-0011}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- In 2022, the overall prevalence of homebound beneficiaries was 22.0% (8.4% of beneficiaries were homebound, and 13.6% were semihomebound).
- In adjusted models, female sex (odds ratio [OR], 1.36 [95% CI, 1.35 to 1.37), low-income status or dual eligibility for Medicare and Medicaid (OR, 1.56 [CI, 1.55 to 1.57]), dementia (OR, 2.36 [CI, 2.33 to 2.39]), and moderate to severe frailty (OR, 4.32 [CI, 4.19 to 4.45]) were predictive of homebound status.
- In multivariable logistic regression, homebound status was associated with increased odds of any emergency department visit (OR, 1.14 [ CI, 1.14 to 1.15]), any inpatient hospital admission (OR, 1.44 [CI, 1.42 to 1.46]), any skilled-nursing facility admission (OR, 2.18 [CI, 2.13 to 2.23]), and death (OR, 2.55 [CI, 2.52 to 2.58]).
- LIMITATION: The study period overlapped the tail end of the COVID-19 pandemic, and data were derived from a single national MA plan, which limits generalizability.
- Overall homebound prevalence in a national MA plan was 22.0% and was independently associated with increased health service use and mortality.
Why it matters
This study found that 22 percent of Medicare Advantage beneficiaries were homebound or semihomebound, and dementia was predictive of homebound status. It does not test any treatment, cure, or prevention for Alzheimer's disease, and it suggests findings can inform strategies to identify and manage care for homebound beneficiaries.
Study details
- Study designcross-sectional
- Effect size22.0%; 8.4%; 13.6%
- Evidence strengthLow
How this study scored 49/100
Published in a leading specialty journal, and it is a snapshot of people at one point in time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Annals of Internal Medicine) |
| Journal's citation record | 4 / 4 | Annals of Internal Medicine: journal h-index 648 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.8 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Katherine A. Ornstein: h-index 48 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39133927) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Health systems and care delivery from nearby years
Also tagged “palliative”
858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.